Modular Medical, Inc. (MODD)

The immediate outlook is severely clouded by a catastrophic multi-year price collapse. Despite a brief, sharp recovery in 2024, the asset has lost over 85% of its value since mid-2022, with the most recent annual period showing another steep decline. This structural deterioration suggests the market has fundamentally reassessed the business quality downward, rendering any short-term technical bounce highly suspect. The company is burning significant cash, reporting negative free cash flow and negative operating cash flow, while posting substantial losses that result in negative earnings per share. The balance sheet shows a concerning debt-to-equity ratio relative to the tiny market cap, and the lack of any dividend history confirms this is a pure growth (or in this case, survival) play with no income floor. While recent headlines highlight product shipments, the financial reality of deep losses and a collapsing stock price indicates the business is struggling to achieve the profitability required to sustain its operations or attract capital. The statistical forecast models also lean slightly negative, reinforcing the view that the current price action is not a reversal of this downtrend.